fda tirzepatide announcement US judge sides with FDA's removal of Lilly's weight loss drug from shortage list The peptide regulatory landscape in

REFERENCES PubReader ePub Link Cite this Article Cite this Article Close Download Citation Close XML Download Figure Fig

Any use beyond its approved indication is off-label and subject to provider evaluation

The thigh offers a practical alternative for patients who prefer not to inject in the abdominal area or who have limited abdominal subcutaneous tissue

Our team is committed to supporting you every step of the way to ensure your treatment is as comfortable and effective as possible

A moment of verification prevents a potentially serious dosing error

But its especially important to stay hydrated if youre dealing with nausea, vomiting, or diarrhea while on tirzepatide